Financials
Financial year 2025
PHARMACIE DEWEZ from Visé, company number BE0433050857, closed financial year 2025 with a result of € -46,256 after tax. For that financial year PHARMACIE DEWEZ recorded a gross margin of € 60,835 and equity of € 102,688. Compared with financial year 2024, the result moved from € 41,096 to € -46,256. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on February 13, 2026.
€ 102,688
▼ 31% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -46,256
▼ still € 41,096 profit in 2024
Profit after tax over the fiscal year.
€ 67,139
▼ 4% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 40,688.
People and assets in 2025
€ 77,012
▲ 26% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 24,888
▲ € 21,953 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 101,279
€ 31,159 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 50,767
▲ 13% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 16,352
▼ 25% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 124,131 | € 138,302 | € 148,223 | € 60,835 | ▼ 59% |
| Profit after taxes | € 24,102 | € 29,683 | € 41,096 | € -46,256 | ▼ € 87,352 |
| Equity | € 118,166 | € 107,849 | € 148,944 | € 102,688 | ▼ 31% |
| Total debts | € 152,141 | € 164,226 | € 164,417 | € 213,894 | ▲ 30% |
| Cash | € 45,694 | € 38,215 | € 69,650 | € 67,139 | ▼ 4% |
| Land & buildings | € 25,380 | € 21,113 | € 16,845 | € 12,578 | ▼ 25% |
| Retained profit | € 56,166 | € 45,849 | € 86,944 | € 40,688 | ▼ 53% |
| Dividend | € 0 | € 40,000 | € 0 | € 0 | |
| Bank debt | € 10,530 | € 2,106 | € 0 | € 101,279 | |
| Balance sheet total | € 270,307 | € 272,074 | € 313,362 | € 316,582 | ▲ 1% |
Key figures of PHARMACIE DEWEZ, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to PHARMACIE DEWEZ?
What happened at PHARMACIE DEWEZ in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- DEWEZ INVEST SRL stepped down as director. NBB
- François LECLOUX stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 46,256 (▼ € 87,352 vs 2024). Source: NBB ↗
- DEWEZ INVEST SRL became a director. NBB
- François LECLOUX became a director. NBB
- New establishment in Visé. KBO
- Start of the company according to the CBE. KBO
In short
From € 24,102 profit in 2022 to € 46,256 loss in 2025.
Paid € 42,478 in corporate taxes since 2022.
Best year ever: 2024, with € 41,096 profit.
Paid out € 40,000 in dividends to the owners in total.
A new publication or filing at PHARMACIE DEWEZ? We notify you, reason included.
Follow PHARMACIE DEWEZDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of DEWEZ INVEST comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE DEWEZThe shares are held by DEWEZ INVEST (100%).
Directors
According to the 2025 annual accounts
Managing director · represented by DEWEZ MARIE
since 2025 · until 2031
François LECLOUX
Director
since 2025 · until 2031
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue du Collège(VIS) 48
4600 Visé
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0433.050.857
- VAT number
- BE 0433.050.857
- Registered office
- Rue du Collège(VIS) 48, 4600 Visé
- Names & denominations
- PHARMACIE DEWEZ
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 30 December 1987
- Peppol
- Active · Active since 13 Jan 2026
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten
Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen